At #AACR21, we presented our research on CD39 driving suppression of inflammation, and the importance of targeting the adenosine pathway in the tumor microenvironment to reduce immunosuppression. View the full poster here: https://t.co/W3smmVrzb7 https://t.co/kPNGV7y1qz